Catalyst Wire Dossier Catalyst Wire Dossier

Oxycodone/naloxone prolonged-release (OXN PR)

oxycodone/naloxone · Mundipharma Research GmbH & Co KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxycodone/naloxone prolonged-release (OXN PR), covering 2016-11-04 to 2016-11-04. Get the full timeline:

Most recent: Clinical Trial Update: To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain [Phase 2, Phase 3]

See pricing